跳轉至內容
Merck
全部照片(1)

文件

BP700

奥布卡因 盐酸盐

British Pharmacopoeia (BP) Reference Standard

同義詞:

4-氨基-3-丁氧基苯甲酸二乙基氨基乙基酯, 丁氧卡因 盐酸盐

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C17H28N2O3 · HCl
CAS號碼:
分子量::
344.88
MDL號碼:
分類程式碼代碼:
41116107
NACRES:
NA.24

等級

pharmaceutical primary standard

API 家族

oxybuprocaine

形狀

solid

儲存期限

limited shelf life, expiry date on the label

製造商/商標名

BP

應用

pharmaceutical
pharmaceutical small molecule

格式

neat

儲存溫度

2-8°C

SMILES 字串

Cl[H].CCCCOc1cc(ccc1N)C(=O)OCCN(CC)CC

InChI

1S/C17H28N2O3.ClH/c1-4-7-11-21-16-13-14(8-9-15(16)18)17(20)22-12-10-19(5-2)6-3;/h8-9,13H,4-7,10-12,18H2,1-3H3;1H

InChI 密鑰

PRGUDWLMFLCODA-UHFFFAOYSA-N

尋找類似的產品? 前往 產品比較指南

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Oxybuprocaine hydrochloride BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Oxybuprocaine Eye Drops
  • 包裝

    Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

    其他說明

    Sales restrictions may apply.

    相關產品

    儲存類別代碼

    11 - Combustible Solids

    水污染物質分類(WGK)

    WGK 3

    閃點(°F)

    Not applicable

    閃點(°C)

    Not applicable


    Choose from one of the most recent versions:

    分析證明 (COA)

    Lot/Batch Number

    Sorry, we don't have COAs for this product available online at this time.

    If you need assistance, please contact 客戶支援

    已經擁有該產品?

    您可以在文件庫中找到最近購買的產品相關文件。

    存取文件庫

    Maurizio Cammalleri et al.
    Frontiers in pharmacology, 12, 671238-671238 (2021-06-25)
    Neuropathic ocular pain is a frequent occurrence in medium to severe dry eye disease (DED). Only palliative treatments, such as lubricants and anti-inflammatory drugs, are available to alleviate patients' discomfort. Anesthetic drugs are not indicated, because they may interfere with

    我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

    聯絡技術服務